Nantahala Capital Partners Limited Partnership

13D and 13G Filings

13D/G filings
13D on 1 security, 13G on 11 securities
Location
New Canaan, CT
CIK
0001502725
Form D filings
19 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Femasys Inc. 13D
FEMY · 31447E204
 10.0% 8/17/2026
Event 8/10/2026
Azitra, Inc. 13G
AZTR · 05479L302
 8.4% 8/14/2026
Event 6/30/2026
Abeona Therapeutics Inc. 13G/A Amendment 1
ABEO · 00289Y206
 5.8% 5/15/2026
Event 3/31/2026
Kiora Pharmaceuticals, Inc. 13G/A Amendment 1
KPRX · 49721T507
 3.4% 5/15/2026
Event 3/31/2026
Curis, Inc. 13G
CRIS · 231269309
 7.0% 4/7/2026
Event 3/31/2026
InspireMD, Inc. 13G/A Amendment 1
NSPR · 45779A846
 5.7% 11/14/2025
Event 9/30/2025
DarioHealth Corp. 13G/A Amendment 1
DRIO · 23725P308
 4.6% 11/14/2025
Event 9/30/2025
Abeona Therapeutics Inc. 13G
ABEO · 00289Y206
 5.1% 10/6/2025
Event 9/29/2025
Kiora Pharmaceuticals, Inc. 13G
KPRX · 49721T507
 5.3% 8/14/2025
Event 8/8/2025
Senti Biosciences, Inc. 13G/A Amendment 1
SNTI · 81726A209
 1.9% 5/15/2025
Event 3/31/2025
Surrozen, Inc./DE 13G/A Amendment 1
SRZN · 86889P208
 2.2% 5/15/2025
Event 3/31/2025
DarioHealth Corp. 13G
DRIO · 23725P209
 5.8% 3/6/2025
Event 2/27/2025
Eagle Pharmaceuticals, Inc. 13G
EGRX · 269796108
 6.2% 2/19/2025
Event 2/16/2025
Senti Biosciences, Inc. 13G
SNTI · 81726A209
 5.9% 2/14/2025
Event 12/2/2024
Unicycive Therapeutics, Inc. 13G/A Amendment 2
UNCY · 90466Y103
 2.8% 12/20/2024
Event 12/19/2024
Unicycive Therapeutics, Inc. 13G/A Amendment 1
UNCY · 90466Y103
 7.8% 11/14/2024
Event 9/30/2024
Surrozen, Inc. 13G
SRZN · 86889P208
 5.3% 11/14/2024
Event 9/30/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.